Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 5—May 2004
Research

Multidrug-resistant Tuberculosis in Central Asia

Helen Suzanne Cox*Comments to Author , Juan Daniel Orozco*, Roy Male*, Sabine Ruesch-Gerdes†, Dennis Falzon*, Ian Small*, Darebay Doshetov‡, Yared Kebede§, and Mohammed Aziz¶
Author affiliations: *Médecins Sans Frontières Aral Sea Area Programme, Uzbekistan and Turkmenistan, Tashkent, Uzbekistan; †National Reference Centre for Mycobacteria, Borstel, Germany; ‡Ministry of Health, Nukus, Karakalpakstan, Uzbekistan; §Médecins Sans Frontières, Amsterdam, the Netherlands; ¶World Health Organization, Geneva, Switzerland

Main Article

Table 2

First-line anti-tuberculosis drug resistance results, Karakalpakstan, Uzbekistana

No. new cases (%) No. retreatment cases (%) Total no. (%)
Total tested 106 107 213
Any resistance 51 (48.1) 86 (80.4) 137 (64.3)
Monoresistance
H only 3 (2.8) 7 (6.5) 10 (4.7)
R only 0 0 0
E only 0 0 0
S only 12 (11.3) 11 (10.3) 23 (10.8)
Z only 0 1 (0.9) 1 (0.5)
H and R resistance
MDR 14 (13.2) 43 (40.2) 57 (26.8)
HR only 0 1 (0.9) 1 (0.5)
HRE only 0 0 0
HRS only 4 (3.8) 10 (9.3) 14 (6.6)
HRZ only 0 0 0
HRES only 6 (5.7) 19 (17.8) 25 (11.7)
HREZ only 0 0 0
HRSZ only 1 (0.9) 0 1 (0.5)
HRESZ 3 (2.8) 13 (12.1) 16 (7.5)
H + other resistance
HE only 0 0 0
HS only 13 (12.3) 15 (14.0) 28 (13.1)
HZ only 1 (0.9) 1 2 (0.9)
HES only 2 (1.9) 4 (3.7) 6 (2.8)
HEZ only 0 0 0
HSZ only 1 (.9) 3 (2.8) 4 (1.9)
HESZ only 5 (4.7) 1 (0.9) 6 (2.8)
R + other resistance
RE only 0 0 0
RS only 0 0 0
RZ only 0 0 0
RES only 0 0 0
RESZ only 0 0 0
Any drug resistance
Any H resistance 39 (36.8) 74 (69.2) 113 (53.1)
Any R resistance 14 (13.2) 43 (40.2) 57 (26.8)
Any E resistance 16 (15.1) 37 (34.6) 53 (24.9)
Any S resistance 47 (44.3) 76 (71.0) 123 (57.7)
Any Z resistance 11 (10.4) 19 (17.8) 30 (14.1)

aH, isoniazid; R, rifampin; E, ethambutol; S, streptomycin; Z, pyrizinamide.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external